摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(4-甲氧基苯基)-2-甲基-1H-咪唑 | 68337-08-6

中文名称
1-(4-甲氧基苯基)-2-甲基-1H-咪唑
中文别名
——
英文名称
1-(4-methoxyphenyl)-2-methyl-1H-imidazole
英文别名
1-(4-methoxyphenyl)-2-methylimidazole
1-(4-甲氧基苯基)-2-甲基-1H-咪唑化学式
CAS
68337-08-6
化学式
C11H12N2O
mdl
——
分子量
188.229
InChiKey
GMTFWFRCTPYXAW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    27
  • 氢给体数:
    0
  • 氢受体数:
    2

SDS

SDS:8a5ed3f5f1dbaaea04a6e2bc8b3c8f2c
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(4-甲氧基苯基)-2-甲基-1H-咪唑氢溴酸potassium carbonate 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 32.0h, 生成 1-(4-Butoxy-phenyl)-2-methyl-1H-imidazole
    参考文献:
    名称:
    Pyrazole and Isoxazole Derivatives as New, Potent, and Selective 20-Hydroxy-5,8,11,14-eicosatetraenoic Acid Synthase Inhibitors
    摘要:
    In a previous paper, we reported the N-hydroxyformamidine derivative HET0016 as a potent and selective 20-HETE synthase inhibitor. Despite its attraction as a potential therapeutic agent for cerebral diseases, the preparation of an injectable formulation of HET0016 was limited by its poor solubility under neutral conditions and instability under acidic conditions. The instability of HET0016 in acidic conditions is due to the N-hydroxyformamidine moiety, which is considered to be essential for the potent and selective activity seen in our previous study. The activity was maintained when the N-hydroxyformamidine moiety was replaced by an imidazole ring (3a; IC50 = 5.7 +/- 1.0 nM), but this was associated with a loss of selectivity for cytochrome P450s (CYPs). However, other azole derivatives such as isoxazole derivative 23 (IC50 value 38 +/- 10 nM) and pyrazole derivative 24 (IC50 value 23 +/- 12 nM) showed potent and selective activities with improved stability.
    DOI:
    10.1021/jm020557k
  • 作为产物:
    描述:
    甲氧苯胺 在 aluminum (III) chloride 作用下, 以 甲苯 为溶剂, 反应 20.0h, 生成 1-(4-甲氧基苯基)-2-甲基-1H-咪唑
    参考文献:
    名称:
    包含在 C2 位被甲基、丙基和苯基封闭的咪唑阳离子的可调谐芳基烷基离子液体 (TAAIL) 的合成和物理性质
    摘要:
    用甲基、丙基和苯基封闭基于咪唑鎓的可调谐芳基烷基离子液体 (TAAIL) 的 C2 位置对其物理化学性质(如粘度和电导率)有很大影响。特别是可以扩大电化学窗口。芳环上的给电子和吸电子取代基可以进一步改变电子密度,这也已通过量子化学 DFT 计算进行了分析。
    DOI:
    10.1002/chem.202202795
点击查看最新优质反应信息

文献信息

  • CuO Nanoparticles Catalyzed C−N, C−O, and C−S Cross-Coupling Reactions: Scope and Mechanism
    作者:Suribabu Jammi、Sekarpandi Sakthivel、Laxmidhar Rout、Tathagata Mukherjee、Santu Mandal、Raja Mitra、Prasenjit Saha、Tharmalingam Punniyamurthy
    DOI:10.1021/jo8024253
    日期:2009.3.6
    nanoparticles have been studied for C−N, C−O, and C−S bond formations via cross-coupling reactions of nitrogen, oxygen, and sulfur nucleophiles with aryl halides. Amides, amines, imidazoles, phenols, alcohols and thiols undergo reactions with aryl iodides in the presence of a base such as KOH, Cs2CO3, and K2CO3 at moderate temperature. The procedure is simple, general, ligand-free, and efficient to afford the
    通过亲核试剂与芳基卤化物的交叉偶联反应,已研究了CuO纳米颗粒的C-N,C-O和C-S键形成。酰胺,胺,咪唑,醇和醇在中等温度下在碱(例如KOH,Cs 2 CO 3和K 2 CO 3)存在下与芳基化物反应。该过程简单,通用,无配体且有效地以高收率提供了交叉偶联的产物。
  • Unique copper–salen complex: an efficient catalyst for N-arylations of anilines and imidazoles at room temperature
    作者:Ankur Gogoi、Gayatri Sarmah、Anindita Dewan、Utpal Bora
    DOI:10.1016/j.tetlet.2013.10.084
    日期:2014.1
    activity of a unique Cu–salen type complex in N-arylation of anilines with arylboronic acids in water. The protocol is found to be applicable for a wide range of electronically diversified arylboronic acids and anilines with excellent yields of the isolated product. Further the scope of this protocol has been extended to the synthesis of various N-aryl imidazoles in iso-propanol.
    我们在这里报告了一种独特的Cu-salen型配合物在苯胺与芳基硼酸的N-芳基化反应中的催化活性。已发现该方案适用于多种电子多样化的芳基硼酸苯胺,且分离出的产物收率极高。此外,该方案的范围已扩展到在异丙醇中合成各种N-芳基咪唑
  • Carbothioamide as Highly Efficient Ligand for Copper-catalyzed Room Temperature Chan-Lam Cross-Coupling Reaction
    作者:Jayantajit Baruah、Kongkona Gogoi、Anindita Dewan、Geetika Borah、Utpal Bora
    DOI:10.1002/bkcs.11248
    日期:2017.10
    The catalytic activity of three N,S‐donor ligands, viz L1 [2‐(4‐methoxybenzylidene)‐N‐phenylhydrazinecarbothioamide], L2 [2,2′‐(1,2‐diphenylethane‐1,2‐diylidene)bis(hydrazinecarbothioamide)] and L3 [2‐(4‐methoxybenzylidene)hydrazinecarbothioamide] has been reported for N‐arylation of imidazoles with arylboronic acids in ethanol at room temperature. The method was found to be applicable in N‐arylation
    三个N,S-给体配体的催化活性,即L1 [2-(4-甲氧基苄基)-N-酰胺],L2 [2,2'-(1,2-二乙烷-1,2-二亚甲基)bis(据报道,在室温下,L3 [2-(4-甲氧基苄基基甲酰胺]可用于在乙醇中将咪唑与芳基硼酸进行N-芳基化反应。发现该方法适用于N-芳基化反应,使各种电子形式的芳基硼酸咪唑的分离收率均中等至优异。发现原位生成的配体(II)络合物2-(4-甲氧基苄基)-N-酰胺(L1)是N-芳基化反应的高效均相催化剂
  • A triazine-phosphite polymeric ligand bearing cage-like P,N-ligation sites: an efficient ligand in the nickel-catalyzed amination of aryl chlorides and phenols
    作者:Farhad Panahi、Fatemeh Roozbin、Sajjad Rahimi、Mohammadesmaeil Moayyed、Aria Valaei、Nasser Iranpoor
    DOI:10.1039/c6ra14367a
    日期:——
    A novel P,N-ligand was introduced for efficient Ni-catalyzed amination of aryl chlorides. Reaction of cyanuric acid (1,3,5-triazine-2,4,6-triol) and trichlorophosphine (PCl3) resulted in the production of a new porous material (TPPM) containing triazine rings with phosphite moieties in a sheet morphology. Cavities in the prepared compound create sites on the surface of the material with appropriate
    一种新型的P,N-配体被引入以有​​效地Ni催化芳基化物的胺化。氰尿酸1,3,5-三嗪-2,4,6-三醇)与三膦(PCl 3)导致了一种新的多孔材料(TPPM)的生产,该材料包含片状形态的具有亚磷酸部分的三嗪环。制备的化合物中的空腔会在材料表面上形成具有适当连接特性的位点,以与属配合用于催化目的。在这种容易制备且可重复使用的P,N-配体的存在下,催化的芳基化物和2,4,6-三芳基-1,3,5-三嗪TAT)保护型苯酚的胺化反应得以有效完成。在温和的反应条件下。更重要的是,TPPM在遵循此协议后可重复使用5次,而其活动没有明显减少。
  • HETEROCYCLIC COMPOUND
    申请人:Takeda Pharmaceutical Company Limited
    公开号:EP2873669A1
    公开(公告)日:2015-05-20
    The present invention provides a compound having a PDE2A selective inhibitory action, which is useful as an agent for the prophylaxis or treatment of schizophrenia, Alzheimer's disease and the like. The present invention is a compound represented by the formula (1): wherein each symbol is as described in the specification, or a salt thereof.
    本发明提供一种具有PDE2A选择性抑制作用的化合物,可用作预防或治疗精神分裂症、阿尔茨海默病等疾病的药剂。本发明是一种由式(1)表示的化合物:其中每个符号如规范中所述,或其盐。
查看更多